Cargando…
Targeted Therapies in Type II Endometrial Cancers: Too Little, but Not Too Late
Type II endometrial carcinomas (ECs) are responsible for most endometrial cancer-related deaths due to their aggressive nature, late stage detection and high tolerance for standard therapies. However, there are no targeted therapies for type II ECs, and they are still treated the same way as the cli...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6121653/ https://www.ncbi.nlm.nih.gov/pubmed/30104481 http://dx.doi.org/10.3390/ijms19082380 |